bluebird bio, Inc.
SICKLE CELL POTENCY ASSAY
Last updated:
Abstract:
Disclosed herein are potency assays for a gene therapy treatment for sickle cell disease. Also disclosed herein are methods for measuring relative potency of a drug product used for the treatment of sickle cell disease.
Status:
Application
Type:
Utility
Filling date:
20 Mar 2020
Issue date:
19 May 2022